Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7-(2-(1-methyl-2-hydroxy-2-phenylethylamino)ethyl)theophylline
2. Cafedrine Hydrochloride
3. Norephendrinetheophylline
4. Norephendrinetheophylline Mono-hydrochloride, (r-(r*,s*))-isomer
1. Norephendrinetheophylline
2. 58166-83-9
3. Cafedrinum
4. 14535-83-2
5. 7-[2-[(1-hydroxy-1-phenylpropan-2-yl)amino]ethyl]-1,3-dimethylpurine-2,6-dione
6. Cafedrine (ban)
7. Schembl147271
8. Chembl2104207
9. Dtxsid50866678
10. 7-(2-(1-methyl-2-hydroxy-2-phenylethylamino)ethyl)theophylline Monohydrochloride
11. D07151
12. 7-[2-(2-hydroxy-1 Methyl-2-phenylethyl-amino)ethyl]theophylline
13. 1h-purine-2,6-dione, 3,7-dihydro-7-(2-((2-hydroxy-1-methyl-2-phenylethyl)amino)ethyl)-1,3-dimethyl- (van)
| Molecular Weight | 357.4 g/mol |
|---|---|
| Molecular Formula | C18H23N5O3 |
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 357.18008961 g/mol |
| Monoisotopic Mass | 357.18008961 g/mol |
| Topological Polar Surface Area | 90.7 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 525 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
C - Cardiovascular system
C01 - Cardiac therapy
C01C - Cardiac stimulants excl. cardiac glycosides
C01CA - Adrenergic and dopaminergic agents
C01CA21 - Cafedrine
Market Place
ABOUT THIS PAGE
61
PharmaCompass offers a list of Cafedrine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cafedrine manufacturer or Cafedrine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cafedrine manufacturer or Cafedrine supplier.
PharmaCompass also assists you with knowing the Cafedrine API Price utilized in the formulation of products. Cafedrine API Price is not always fixed or binding as the Cafedrine Price is obtained through a variety of data sources. The Cafedrine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cafedrine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cafedrine, including repackagers and relabelers. The FDA regulates Cafedrine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cafedrine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cafedrine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cafedrine supplier is an individual or a company that provides Cafedrine active pharmaceutical ingredient (API) or Cafedrine finished formulations upon request. The Cafedrine suppliers may include Cafedrine API manufacturers, exporters, distributors and traders.
click here to find a list of Cafedrine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Cafedrine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cafedrine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cafedrine GMP manufacturer or Cafedrine GMP API supplier for your needs.
A Cafedrine CoA (Certificate of Analysis) is a formal document that attests to Cafedrine's compliance with Cafedrine specifications and serves as a tool for batch-level quality control.
Cafedrine CoA mostly includes findings from lab analyses of a specific batch. For each Cafedrine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cafedrine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cafedrine EP), Cafedrine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cafedrine USP).
